Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Reduction of Antipsychotics in Schizophrenia
NCT03019887Completed
- Sponsor
- Juntendo University
- Start
- Apr 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole and 3 more in schizophrenia, sponsored by Juntendo University. Primary endpoint: Number of Participants With Relapse at 1 year. Started Apr 2011; status: completed.
02
Drugs
risperidonehaloperidololanzapinequetiapinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03019887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03019887.